• Company CEO Riggs Eckelberry talks about recent big win in Spain
• OriginClear business model creates licensing agreements with diverse industries that create applications of proprietary water-treatment technology
• OriginClear empowers businesses to take control of their water while also helping improve their environmental, social and governance (ESG) standings

A foremost provider of water-treatment solutions, OriginClear Inc. (OTC: OCLN) offers modular water-treatment and conveyance products that enable water independence and help make clean water available for all. Recently, the company’s CEO Riggs Eckelberry was featured in a television interview discussing OriginClear’s recent success and upcoming initiatives.

During the interview, Eckelberry noted the company’s big win in Spain, where Depuporc, a Spanish enterprise specifically focused on wastewater treatment on hog farms, is utilizing OriginClear’s technology. An OriginClear licensee, Depuporc has created a commercial-scale system that can treat 30 tons of wastewater per day: an important step in the process of treating pig manure effluent for the global livestock industry. Eckelberry explained that a 2,500-head dairy farm generates as much waste as the city of Miami. OriginClear’s technology effectively deals with the enormous plumes of pollution – especially ammonia – that are created by these farms. Thanks to OCLN’s ground-breaking technology and systems, sludge water becomes clear water. This technology will allow Spanish pork producers to achieve EU approval and expand their farms.

OriginClear’s business model is to create licensing agreements with diverse industries that create applications of the water-treatment technology (http://ibn.fm/AiWca). Licensees are building products worldwide using OriginClear’s low-energy, chemical-free innovation. Eckelberry noted that OriginClear now has a remarketing agreement that allows the company to take Depuporc’s integrated manure-treatment system using OriginClear’s technology and sell it as an application globally. Looking ahead to 2020, OriginClear will be concentrating on acquiring companies to facilitate growth and secure a more dominant position in the decentralized water space.

OriginClear’s inventive technologies offer a myriad of benefits to business owners. Not only do they enable businesses and point-of-use water users to be more independent and self-reliant, they can also improve their asset value. Additionally, the company is helping businesses decrease their carbon footprint by cleaning their water on-site. OriginClear is also protecting the water going into the ground. All these efforts result in improving the environment and people’s health and well-being.

OriginClear’s mission is to add value to businesses. The company provides modular water-purification systems, storage systems, pump stations, and wastewater systems, as well as control systems. With a focus on commercial and industrial applications, the company serves the commercial, real estate, hospitality, food and beverage, and business parks industries, as well as the industrial, oil/gas/energy, agriculture, pharmaceutical and manufacturing spaces.

OriginClear is leading decentralized water-treatment innovation with its Modular Water Systems™ product line for treatment and conveyance. These systems can be trucked on-site quickly and inexpensively and utilize unique, super-durable materials (http://ibn.fm/qkdLc). Additionally, OriginClear is commercializing Electro Water Separation™ with Advanced Oxidation™, which is a patented, chemical-free technology that cleans extremely dirty, oily water and removes microtoxins.

OriginClear also helps corporations improve their environmental, social and governance (ESG) standings with world-class water management. Of note is that 35% of all treated water is lost during conveyance because of failing infrastructure. Consequently, untreated “dirty” water substantially increases carbon footprint and adds to global warming. OriginClear helps businesses improve their ESG ratings by treating water onsite before conveyance to reduce the risk of treated water being lost during conveyance.

OriginClear continues to execute on its mission to restore water to its original pure condition by strengthening its marketing efforts and telling the story of its innovative products. With the significant advancements and test results being made, the company offers investors the potential for significant ROI.

Headquartered in Los Angeles, California, OriginClear offers revolutionary products that effectively improve the quality of the planet’s waters by returning them to their original and clear condition. OriginClear’s emphasis is decentralized water wealth, enabling businesses to take their own water into their own hands versus relying on municipalities.

For more information, visit the company’s website at www.OriginClear.com

NOTE TO INVESTORS: The latest news and updates relating to OCLN are available in the company’s newsroom at http://ibn.fm/OCLN

• SGLB president and CEO discusses disruptive 3D metal-printing technology and how it will reconfigure factory operation
• 3D metal printing is recognized as disruptive technology that can enhance numerous industries, including defense operations and capabilities
• Sigma Labs is set to harness benefits of focused efforts from 2019 in the upcoming year
• 3D metal printing is a multibillion-dollar market

Sigma Labs Inc. (NASDAQ: SGLB) President and CEO John Rice recently joined NNW’s Stuart Smith to discuss the company’s disruptive technology (http://ibn.fm/nls82). A leading developer of quality-control software for the commercial 3D-printing industry, SGLB offers PrintRite3D® software: a proprietary, real-time, computer-aided inspection (CAI) technology. The product is unique as the only in-process, quality-assurance software that revolutionizes the commercial 3D metal-printing industry by enabling nondestructive quality control intervention during the production process.

Sigma Labs was founded in 2010 by a team of senior scientists and engineers from Los Alamos Labs who were poised to develop revolutionary parts in metallurgy science. Managed by experts from different science disciplines such as physics, metallurgy, mechanical engineering, optics, artificial intelligence and data science, the company has become the go-to 3D-metal-printing source for quality control disruptive solutions.

While Rice acknowledges that today “disruption” is an overused term among industry practitioners and academics alike, the SGLB CEO notes that 3D printing is a disruptive technology that revolutionizes the way items – everything from consumer products to heavyweight industrial machinery – are created. SGLB technology will help reconfigure how factories operate in the future, transforming the facilities into Internet of Things factories that will be redesigned along the entire value chain, he says.

Among other industries, additive laser powder bed manufacturing (or 3D metal printing) is recognized as a disruptive technology that can considerably enhance all of manufacturing, especially the defense industry’s operations and military capabilities. Offering solutions such as unmanned and autonomous robotic systems, directed-energy weapons, human performance modification and cyber capabilities, 3D printing is set to transform warfare.

3D-printing technology allows on-demand production, improving the supply-chain responsiveness and reducing inventory, obsolescence risks and total costs. In addition, small scale, or “one-off” production, is viable with this technology because no economies of scale are needed, and standardization is no longer a requirement. As the technology matures, parts could be printed on-site from available materials.

Although 3D printing is considered a key technology that enhances the capabilities of the defense industry, a real challenge remains in the quality-control procedures as inspecting and testing complex shapes is costly and difficult. The 3D metal-printing technology has faced significant difficulties in producing highly consistent, repeatable, quality parts.

Sigma Labs’ technology solves this difficulty by allowing the parts to be monitored in real time during the production process while its flagship revolutionary software, PrintRite 3D, is extracting and assessing thermal information when a part is beginning to drift out of specification. The software is able to spot the precursors of quality issues and alert the machine operator, who can stop and make a correction immediately.

Even with quality-control challenges, 3D metal printing is a multibillion-dollar market. Verified Market Research valued the global 3D-printing market at $8.08 billion in 2017 and projected a CAGR of 25.5% from 2018 to 2025, when the market is expected to reach $49.74 billion.

These impressive growth rates have attracted considerable attention from investors, who have been investing heavily in 3D-printing companies, both public and VC backed. The sector’s growth potential could be even more spectacular with Sigma Labs’ technology solving major obstacles that prevent production at scale.

After a year of intense work, Sigma Labs currently has six major enterprise companies – three OEMs and three end users – that will be completing the test-and-evaluation phases of Sigma Labs’ equipment over the next months. SGLB has spent 2019 validating efficacy while moving toward full commercialization and is poised to harvest these efforts in this year.

For more information, visit the company’s website at www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• Wonderfilm Media Corporation is a new, up-and-coming entertainment production and acquisition house building on its executives’ experience at turning relatively low budgets into much higher gains
• Wonderfilm is establishing a toehold in the growing subscription video on demand industry by providing celebrity-fronted projects to SVoD outlets that are continually searching for more content
• Most importantly, the company is backed by five successful Hollywood producers, who have produced over $1 billion in box office revenue
• Nicolas Cage, John Travolta, Guy Pearce, Felicity Huffman, and Tara Reid are among the celebrities signed to the company’s 2019-2020 project slate

Cord cutters have gained a growing measure of control on-the-go over their entertainment choices thanks to the rise of streaming video services, creating the seeds of a free-the-cable-box future and more democratic approach to film studio production in the process.

British Columbia-based film production house Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) is taking advantage of streaming consumers’ openness to “indie” entertainment options that don’t have the trappings of a blockbuster franchise, bringing developed scripts with celebrity backing to the screen using a strategic budget model that aims to turn significant profits from controlled front-end costs.

A recent NetworkNewsWire editorial noted Wonderfilm’s emergence in a competitive new subscription video on demand (SVoD) market that may rely on newer production companies to feed the belly of the entertainment industry beast as alternatives to higher budget offerings (http://ibn.fm/1iaEh).

“As digital streaming steadily eclipses all other forms of in-home entertainment delivery, an entertainment war has erupted among leading subscription video on demand (SVoD) providers. These streaming wars have opened the gate for newer production companies to step up and cash in by funneling fresh content to hungry SVoDs. The battle has already resulted in some big winners, including film-production companies, such as Wonderfilm Media Corporation,” the editorial states.

Variety magazine reported earlier this year that the largest media companies are spending about $107 billion annually on global content. Wonderfilm productions develop a script and a commitment from a celebrity into a movie pre-sale for an average of about $5 million with about $500,000 to $750,000 of that amount remaining in-house as commissions.

The company retains ownership rights to the film, banking on the potential for profits that will begin to roll in once the revenue terms outlined in the contracts are fulfilled if the films are successful.

The first day cameras start rolling, Wonderfilm begins receiving returns from the production budget that range from $50,000 to $500,000 according to the production line-item fees contracts (http://ibn.fm/vgwQx).

Although the fledgling company is less than two years old, its executives have gained experience employing similar models on previous projects, such as the sleeper hit Get Out and The Hurt Locker. Their work in the film and television industries have also granted them access to the celebrities who have headlined their projects.

Thus far, Wonderfilm’s slate of developed or in-development projects have featured household names such as John Travolta, Guy Pearce, Felicity Huffman, Tara Reid and Nicolas Cage.

For more information, visit the company’s website at www.Wonderfilm.com

NOTE TO INVESTORS: The latest news and updates relating to WDRFF are available in the company’s newsroom at http://ibn.fm/WDRFF

• CIIX CEO speaks to attaining profitability in 2020 as company grows revenue
• Subsidiary CBD Biotech and CBD cosmetics instrumental in driving CIIX’s growth
• CIIX leadership focusing on cost cutting, maintaining profitability, and increased revenue with high margin product sales

ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang spoke optimistically about his company’s growth potential in a recent MoneyTV interview with host Donald Baillargeon. Wang said the company would focus in 2020 on building more revenue from high margin products and cutting costs to achieve profitability. He also emphasized the important role subsidiary CBD Biotech and CBD-infused cosmetics products would play in China.

He cited the high gross margins of CBD cosmetics for the company and said the firm would work to bring more of that profitability down to the bottom line through lower costs and restructuring. CIIX offers a variety of products in its line, ranging from hemp wine to CBD-infused cosmetics.

“We can achieve in cosmetic products a 10X to 20X profit margin. That’s quite a big profit,” Wang said in the interview (http://ibn.fm/d7fZH). “Our goal is to make the company healthier by stabilizing it and making it not as reliant on the street for financing.”

Facing competition and regulatory challenges, Wang’s strategy is to increase product sales to consumers in 2020 and increase focus by splitting the company into smaller strategic components labeled the B2B and B2C divisions. The B2C division, he said, would focus on marketing and selling to consumers while the B2B division would be responsible for maximizing revenue to wholesalers and through multi-level social media outlets. Together, their aim is to raise sales, cut costs and achieve profitability.

Its subsidiary CBD Biotech in China will then leverage its main asset: its customer base of 40,000 consumer clients. “We are going to use this database of the 40,000 repeat customers and analyze it with CRM software, and then we will try to analyze how to encourage our customers to buy more of our products,” Wang said.

In an earlier letter to CIIX shareholders, Wang noted CIIX’s intent to streamline its operations and maximize current resources across the board to achieve profit. As it refocuses on its core investor relations business and continues to build on to its industrial hemp-infused product line in China and the U.S., Wang is optimistic. “Although we still have work to do in this regard, with these objectives in mind, with a dedicated and experienced management team, and most importantly, the continued support of our loyal shareholders, we look forward to a healthy FY2020,” Wang added in a news release (http://ibn.fm/9oAEu).

Wang also described the company’s goal to diversify its revenue streams in FY2020. It plans to focus on its core investor relations business as well as continue to expand and market its industrial hemp-infused/CBD products in China and the United States for greater revenues and profits.

CIIX offers its audience of Chinese-speaking investors real-time market commentary, analysis and educational-related services in Chinese character language sets.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• SING reports 176% revenue growth for Q3 2019 – largest ever for the company
• Explosive growth of 2019 forecast to continue into 2020
• Company distributing, debuting new line of JTI USA’s PrimeTime Little Cigars at 2019 MJBIZCON Show

Singlepoint Inc. (OTCQB: SING), which specializes in acquisitions of small to mid-sized companies with an emphasis in new technologies, is celebrating results from an impressive Q3 resulting from multiple strategic ventures. The recent acquisition of Direct Solar, product launches of PURE hemp products and distribution agreements within the hemp industry are providing investors opportunity across a wide range of assets.

During an interview on MoneyTV.net with Donald Baillargeon (http://ibn.fm/WoWQl), SING President Wil Ralston shared excitement as the explosive growth of 2019 looks to continue into 2020. Ralston noted that SinglePoint has surpassed expectations in the solar business and, in the hemp industry, has seen positive growth with its new line of 1606 Original Hemp Cigarettes and additional distribution agreements.

In Q3 2019, SING reported its largest-ever revenue growth of 176% (http://ibn.fm/dEciw). Direct Solar has surpassed its numbers month over month and continues to expand into new markets. The new acquisition has more than 55 agents, a partnership with 47 Texas schools and a team of dedicated people driving the sales through a multiprong approach to homeowners and corporate businesses. SinglePoint is continuing to accrue $1 million a month in contracts. Ralston stated that SING is excited to continue to show shareholders just how big the solar play will be moving forward.

In addition, SinglePoint had great success launching PURE at the National Association of Convenience Stores (NACS) Show in October and is looking forward to attending the 2019 MJBIZCON show in Las Vegas. Ralston noted that the company will be releasing its new 1606 Original Hemp product at the show.

While SING is developing an ecommerce site for the brand (http://ibn.fm/ai8f9), the hemp pre-rolls will not be available until the show in Las Vegas, although pre-orders have been taken. SING has also signed an agreement with AFG Distribution of North Carolina to sell, market and distribute the filtered hemp pre-roll (http://ibn.fm/xSzd3). This agreement will expand sales into an estimated 8,000 retail accounts. “Teaming with AFG and their impressive sales team accelerates our plan to put finished goods in front of consumers,” Don Smith, vice president of sales for SING, noted in a news release.

SING has also announced a distribution agreement with JTI USA, a multibillion-dollar organization with international presence in 130 countries (http://ibn.fm/QuFyX). In addition to debuting the 1606 Original Hemp pre-rolled product, SING will represent – and take orders for – JTI’s PrimeTime Little Cigars debut. This product has already become known as the “best-flavored little cigars” on the market. PrimeTime™ has built a reputation as a leading consumer over the last 20 years and has been in major accounts such as Circle K and 7-Eleven.

“I’m excited and honored to be working with JTI to distribute PrimeTime Little Cigars,” SING CEO Greg Lambrecht stated in a news release. “The opportunity to work with a global leader in this category is exciting, and we are ready to expand Primetime’s U.S. market share with our unique experience in alternative markets. Having placed premium cigars in over 20,000 accounts, we expect this opportunity to be one of our major revenue sources in coming years, and to distribute additional JTI products as we grow this category.”

SING is already slated to attend two more shows in Q1 2020: The Food and Beverage Show and the Alcohol and Tobacco Show.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• Trxade targeting all 24,000 independent pharmacies across the U.S., with total purchases of $93 billion a year
• Company’s online platform currently has about 11,500 pharmacies as registered users and grows by roughly 100 users every month
• Proceeds from IPO to be used as working capital and to fund future acquisitions

Business-to-business pharmacy services supplier Trxade Group Inc. (OTCQB: TRXD) intends to raise $5 million in an IPO of its common stock on Nasdaq, according to a Seeking Alpha report. The net proceeds will primarily be used as working capital and for general corporate purpose, as well as the possible acquisition of other companies, technology and products, the article says, underlining that the final amount raised under the IPO may differ (http://ibn.fm/8Ada4).

Seeking Alpha also notes that Trxade Group is profitable and has grown from a small revenue base but warns against the risk of an unfocused approach given the company’s disparate operations that face tough competition. Trxade’s main focus is to operate an online pharmacy B2B marketplace for pharmaceutical products and other business segments.

Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; the B2B trading platform, licensed virtual Wholesale and Mail Order Pharmacy capabilities including the mobile app DelivMeds, as well as the newly acquired assets of Bonum Health, a Telemedicine Platform. Delivmeds makes it possible to deliver dispensed prescriptions on the same day.

Trxade’s proprietary web-based e-commerce platform enables trade among pharmaceutical, accessory, and service buyers and sellers. The platform currently has about 11,500 pharmacies as registered users, through which it reaches between 12 million and 15 million patients. The company aims to reach most, if not all, of the estimated 24,000 independent pharmacies currently operating in the U.S., with combined pharmaceutical purchases of $93 billion per year. The U.S. pharmaceutical industry, which is worth $330 billion, is comprised of 1,500 state-licensed suppliers and more than 65,000 pharmacy facilities, 24,000 of which are independent.

Trxade’s trading platform offers users a series of measurable benefits, including significant discounts that contribute to a 7-10 percent decrease in the annual purchase expenses for pharmacies; no registration and transaction fees for pharmacies; a simple and intuitive interface that helps pharmacies compare prices and select the best offer with guaranteed security for purchases and payments.

The U.S. health care market is currently valued around $4 trillion. As the general population ages, further growth is expected, which in turn will have increasing impact on consumers as out-of-pocket expenses rise as well. Medication costs are expected to increase faster than the inflation rate and the general health care and variable drug pricing provides great opportunity for the company’s established model of price visibility.

Trxade aims to lower prescription drug costs by attacking the inefficient value chain, delivering drugs directly to independent pharmacists and consumers, and offering efficient purchasing and price transparency. Its integrated drug procurement, delivery and healthcare platform also delivers increased profit margins.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

• Online sales of the global dental equipment and medical supplies market totaled $40 billion in 2018, growing at 17% per annum compared with a 2% revenue growth rate at brick-and-mortar shops
• No Borders subsidiaries active in two rapidly growing markets at the moment: blockchain technology and hemp
• Worldwide spending on blockchain solutions to grow to $11.7 billion by 2022 while global sales of hemp estimated to reach $5.73 billion by 2020

No Borders Inc. (OTC: NBDR) has executed a distribution and direct supply agreement with KB Dental of South Korea for the latter’s line of specialty dental and endodontic products, including the brands Kerator, MCT Bio and Maruchi. Under the agreement, KB Dental will supply No Borders’ subsidiary No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies, with a diverse product line ranging from Endosonic systems to EndosealMTA pastes. These high-value specialty products are in high demand by endodontic offices across the U.S.

The world-class MCT Bio, Mariuchi and Kerator product lines are a hallmark example of No Borders’ commitment to all-around excellence across the NBDR family of companies. “I am extremely proud of everyone on the NBDR teams for the continual effort and work put into establishing MediDent Supplies as an industry-leading, low-cost provider in these specialty dental sub-verticals. (…) We are very pleased to offer KBs products to our customers all over America,” No Borders CEO Joseph Snyder stated in a news release (http://ibn.fm/hT1Gf).

No Borders is a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority across its portfolio of assets. It is uniquely positioned to use its expertise to improve margins with active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology.

No Borders’ other subsidiaries operate in two of the most popular and fast-growing markets at the moment: hemp and blockchain. These subsidiaries include No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets, and No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies and consulting, architecture and software development services to external businesses.

In 2018, the global sales of hemp amounted to $3.74 billion and estimated to reach $5.73 billion in 2020 (http://ibn.fm/YT8xZ). Hemp is a safer investment than marijuana because hemp-based businesses have fewer reporting requirements. As a result of the 2018 Farm Bill, the sale of hemp-derived CBD products was legalized at federal level as long as the products contain less than 0.3% tetrahydrocannabinol, the compound responsible for cannabis’ psychoactive properties. Individual states set up their own regulatory programs governing hemp, which most of them have already done (http://ibn.fm/VFigt). Recently, banking institutions across the U.S. were given the green light to do business with hemp-related companies, as a result of hemp being delisted as a Schedule 1 controlled substance. This development is likely to further fuel the industry’s growth.

Another No Borders subsidiary that operates in both the hemp and blockchain markets, CBD LabChain, records Certificate of Authority (COA) on a blockchain technology platform, making it an indispensible tool that brings a sense of security to consumers of CBD products in an unbiased and unchangeable way. To give consumers this much-needed peace of mind, No Borders Labs designed CBD LabChain to record THC, CBD and other lab test data and make results easily accessible via QR code linkage as well as a clear Results “Guaranteed with Blockchain” icon, which can be integrated directly into individual product labels.

Blockchain-based certificates and authentication are becoming increasingly popular. The same idea is behind a joint project of the Chamber of Industry and Commerce of Munich and Upper Bavaria, Germany, and the country’s Digital Ministry, to use blockchain technology as an “authentication stamp.” More specifically, the two bodies will issue their first blockchain-enabled training certificates next spring, marking the first step for the concrete use of blockchain in administration. In the future, employers will be able to determine whether the certificates are genuine with the help of an electronic key. This kind of blockchain-enabled certification can be extended to any type of document, according to German authorities (http://ibn.fm/0IZec).

As the blockchain market continues to expand, it is expected to be incorporated in a growing number of practical applications. According to Statista, worldwide spending on blockchain solutions is expected to grow from $1.5 billion in 2018 to an estimated $11.7 billion by 2022 (http://ibn.fm/r1pD0).

For more information, visit the company’s website at www.NBDR.co

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at  http://ibn.fm/NBDR

• HTC Extraction Systems specializes in ethanol and ethanol-based solvent extraction and product reclamation, which it is using in processes designed to build its position in the booming cannabinoid market
• Cannabidiol (CBD) has proven to be the most readily available and profitable cannabinoid for use in the non-pharmaceutical wellness industry, growing 342 percent in year-over-year sales between August 2018 and August 2019
• HTC is establishing biomass receipt, refining and retail operations in Canada and the United States (California) to take advantage of is technical experience and the consumer demand for cannabinoid products

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) is approaching its end of year operations riding high on a series of strategic decisions designed to establish a modular, economical production chain for obtaining hemp, extracting profitable chemical compounds and distributing those compounds through sales-to-consumer marketplaces.

HTC has established proprietary systems to reduce costs and boost its ecological profile while specializing in ethanol extraction and purification, using biomass to obtain cannabinoids such as cannabidiol (CBD), cannabigerol (CBG) and cannabinol (CBN). HTC’s trademarked Delta CBD Reclaiming System recovers and purifies ethanol and solvents with the end of meeting food-grade requirements for extracted CBD quality, utilizing HTC’s experience in reduced-heat processing to prevent damage to CBD molecules’ chemical attributes.

Likewise, HTC’s trademarked Delta Reclaiming System reclaims ethanol and hydrocarbon-based solvents, and others, for use in hemp biomass cannabinoid extraction processes, natural gas processing and post-combustion carbon dioxide capturing for the best-possible environmental footprint.

HTC’s clean energy approach gives the company a measure of additional gravitas in a booming industry defined by rapidly shifting public perspectives that have driven communities and states to battle long-established federal drug-industry regulations that many people now regard as onerous.

Cannabinoid users are already reporting the benefits of non-psychoactive cannabinoids in dealing with pain, nerve, muscle disorders and other health issues at the same time that natural product alternatives to the prescription drug market were gaining a strong foothold in the consumer wellness marketplace. Natural products industry market researchers at data technology company SPINs reported recently that CBD sales grew 342 percent year-over-year between August 2018 and August 2019, reaching $185.1 million in revenue – well above the $9.1 million level reported two years ago (http://ibn.fm/gnoRQ).

CBD’s ascendance drove an interest in less-available, harder-to-market cannabinoids such as CBG and CBN. CBG exploration began to take off in 2015 but the difficulty in obtaining sufficient quantities for retail products has hindered wide-scale use. CBN has similarly suffered, despite its reputed potential for counteracting some of the negative effects of other cannabinoids, particularly psychoactive cannabinoids. But the U.S. government’s National Center for Complementary and Integrative Health (NCCIH) announced last year that it intends to launch its own research on lesser-known cannabinoids because of their potential health benefits (http://ibn.fm/ULo0t).

HTC has used hemp biomass tolling contracts as an economical model for obtaining plant product and is installing new extraction equipment this month at its recently-completed 19,000-square-foot facility in Saskatchewan and at the 22,000-square-foot facility in California owned by Starling Brands Inc., with whom HTC has established a share and purchase agreement for hemp extraction, refining, formulation and distribution in that state.

HTC intends to use its relationship with Purely Canada Foods™ to market its cannabinoid ingredients under the brands Purely Canada Hemp™, Purely Canada CBD™, Purely Canada CBG™ and Purely Canada Cannabinoids™, building multi-year ingredient supply contracts with its customers.

The company built its revenues by more than 2.5 times in year-over-year financial results reported recently for the third quarter, growing from $1.3 million to $3.3 million (http://ibn.fm/yeNCo).

For more information, visit the company’s website at www.HTCExtraction.com

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://ibn.fm/HTC

• Vocal, JMDA’s social publishing platform, achieves impressive Alexa ranking—in part due to release of Vocal 2.0
• Jerrick’s Q3 revenue figure of $91,386 represented nearly a 100% increase over a combined $41,515 for the first two quarters of fiscal year 2019
• Q4 revenue is expected to be approximately $305,000-$315,000

In his weekly update, Jerrick Media Holdings Inc. (OTC: JMDA) CEO Jeremy Frommer discussed the company’s growth strategy, recent achievements, and upcoming rebranding. He announced the company’s intended focus on expanding its technology and “cultural ecosystem,” which he anticipates “should result in exponential value for shareholders.” To mark this next chapter in its evolution, the company will undergo a rebranding, transitioning from Jerrick to Creatd in the near future (http://ibn.fm/WtUvg).

Frommer began his report with a review of the company’s financial successes. The company’s current revenue expectation of approximately $305,000-$315,000 for the fourth quarter 2019 is in line with previous public guidance. This is as compared to the $91,386 in revenues reported for the third quarter, over a 300% increase. The revenue figure of $91,386 represented nearly a 100% increase over a combined $41,515 for the first two quarters of fiscal year 2019 (http://ibn.fm/hnKJU). Significantly, this past week was the seventh in a row that Jerrick’s stock maintained above the $4.00 threshold (http://ibn.fm/qVTpH).

After providing these financial details, Frommer described what he saw as one of a CEO’s essential duties: “communicating and putting together the public pieces of the corporate narrative.” He conveyed his passion for educating shareholders on the company’s strategy to achieve ultimate transparency. “I have found time and time again that explaining the business strategy and actually meeting expectations builds lasting investor confidence. I suggest that this was a big part of how Jerrick’s largest shareholders accumulated their positions over time,” Frommer said in the update. “Educating them and instilling in investors a deep understanding of the company creates long term value. Repeated confidence based on previous execution and behavior by a CEO can create a self-propelling cycle for a company’s valuation and financing flexibility for future growth or acquisitions.”

Frommer also outlined the company’s plans for continued growth. Vocal – Jerrick’s proprietary, long-form, social publishing platform that uniquely partners with creators to let their “voices” be heard – has been gaining traction among third party marketing platforms that understand the value of collaborating with Vocal as a key part of their distribution channels.

“There is scalable demand for a number of our brand-oriented products and services launching over the next sixty days, including a new Vocal product feature called Challenges, which will maximize our ability to efficiently scale revenues while continuing to expand the platform’s brand offerings,” Frommer added. “Challenges, expected to launch in January 2020, are themed story contests that offer the creator a new avenue through which they can be rewarded for their content.”

Creators can enter various Challenges, potentially winning cash prizes, brand interactions, and more. Additionally, Frommer reported significant sponsorship interest from well-known brands hoping to collaborate directly with the Vocal platform. He indicated that results from the company’s beta tests suggest a trend between the introduction of Challenges and a significant increase in creator lifetime value (LTV).

After detailing the launch of Vocal 2.0, which included strategic upgrades, Frommer described the significance of Jerrick’s Alexa ranking and how it can translate into overall success for a company. “There’s a reason we’ve monitored this metric obsessively over the years,” Frommer explained. “The Alexa score is a foremost indicator of a website’s popularity.”

“With a newly fortified platform, an internal management team as sophisticated as ours, and our technology being continuously validated both in our revenue growth and our traffic metrics, we’re confident the growth we’ve seen so far is just the beginning for Vocal,” Frommer stated.

Jerrick Media Holdings Inc., a holding company that develops technology-based solutions, is focused on the development of digital communities, targeted marketing of branded digital content and e-commerce opportunities. To accomplish these objectives, Jerrick envisions, designs, and builds modern technology companies that redefine how people interact with technology. As the parent company of Vocal, Jerrick has built and shipped products that have influenced millions of people worldwide.

Sign up for weekly news from Jerrick by providing your email at https://jerrickmedia.typeform.com/to/TGIfCy

For more information, visit the company’s website at https://Jerrick.media

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at  http://ibn.fm/JMDA

• Zacks has reiterated support for their initial $4.44 share price target for Pressure BioSciences
• PBIO’s fundamentals remain strong, with record sales of consumables and increased revenue from products and services over same quarter previous year
• Company anticipates doubling of total revenue in 2020, driven by anticipated sales of their proprietary BaroShear K45 System, which provides the CBD market with much-needed, superior water-soluble nanoemulsions of CBD Oil

Zacks Small Cap Research, a division of Zacks Investment Research, has announced that they are maintaining their strong $4.44 share price target originally stated in their initial coverage of Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the sale and development of pressure-based consumables, instruments, and platform technology solutions to the global life sciences industry. PBIO’S unique and enabling pressure platform technologies can be used in many large and growing markets (e.g., food preservation, medical/lab applications, and, importantly, CBD oil water solubility).

The Zacks report (http://ibn.fm/z1W3H) points to demand that “is expected to accelerate starting in 2020,” which nonetheless follows many years of consistent yearly revenue increases by PBIO. The company itself is standing by its stated anticipation of doubling revenue in 2020, due to expected sales of their soon-to-be-released $200,000 BaroShear K45 systems. These new instrument systems utilize PBI’s proprietary Ultra Shear Technology™ (UST) platform to effectively produce high quality, long-term stable, water-soluble nanoemulsions of CBD Oil (http://ibn.fm/PFora).

True water-soluble CBD is now seen as critical to the CBD market, since water-solubility is necessary for bioavailability. It also allows for accurate dosing for consumers, something that has been sorely missing up to now. Without accurate dosing, you can’t really control the amount of CBD that actually gets into the bloodstream and available by the consumer. In essence, it doesn’t matter how organic or potent a company says their CBD is, if it is not truly water soluble then it is not going to be properly absorbed by the body and will be largely excreted. PBIO’s revolutionary, patented, and highly anticipated UST-based BaroShear K45 system is expected to provide superior water-solubility, long-term shelf stability, improved safety, and significantly increased bio-availability compared to current nanoemulsification methods, overcoming key weaknesses of the other approaches.

The BaroShear K45 features a unique, highly efficient, customized ultra-high pressure (UHP) subsystem generating pressure levels of up to 45,000 psi. The system’s maximum throughput capacity is one liter per eight hours. The platform is also suitable for processing small volumes (e. g., min. 20 ml) of high-quality CBD oil into a water-soluble nanoemulsion with minimal production loss.

To view the full Zacks report, visit http://ibn.fm/z1W3H

For more information, visit the company’s website at www.PressureBioSciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO